Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 4398-4402, December 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loewenstein, P. M.
Right arrow Articles by Gerard, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loewenstein, P. M.
Right arrow Articles by Gerard, G. F.

Distribution of DNA Polymerase Cm in Normal and Malignant Human Tissues1

Paul M. Loewenstein2, Gary W. Lange and Gary F. Gerard

Institute for Molecular Virology, St. Louis University School of Medicine, St. Louis, Missouri 63110

The distribution in human tissues has been determined of the new DNA polymerase activity designated DNA polymerase Cm, first isolated from the human melanoma cell line A-375. Tissue samples were fractionated by ion exchange chromatography on diethylaminoethyl cellulose and phosphocellulose and by affinity chromatography on poly(2'-O-methylcytidylate)-Sepharose. DNA polymerase activity was monitored with poly(2'-O-methylcytidylate)·oligodeoxyguanylate and poly(adenylate)·oligodeoxyribothymidylate, the most specific and most sensitive template primers, respectively, for DNA polymerase Cm. Tissues were scored as to presence or absence of detectable DNA polymerase Cm activity as well as to their validity for scoring dependent on content of total DNA polymerase activity. On this basis, seven of 14 malignant and none of 11 normal or embryonic tissues were found to contain detectable levels of DNA polymerase Cm.

1 Supported by Contract NO1 CP 61049 within the Virus Cancer Program of the National Cancer Institute.

2 To whom requests for reprints should be addressed.

Received 4/18/80. Accepted 8/15/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.